We are live on ! Find out more
ECM

ExodusPoint Capital Management Portfolio holdings

AUM $12.6B
1-Year Est. Return 30.13%
This Fund
S&P 500
This Quarter Est. Return
+0.61%
1 Year Est. Return
+30.13%
3 Year Est. Return
+85.63%
5 Year Est. Return
+104.04%
10 Year Est. Return
AUM
$14.7B
AUM Growth
+$1.55B
Cap. Flow
-$42.4M
Cap. Flow %
-0.29%
Top 10 Hldgs %
33.58%
Holding
2,110
New
660
Increased
423
Reduced
368
Closed
648

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$231M
2
COP icon
ConocoPhillips
COP
+$114M
3
AAPL icon
Apple
AAPL
+$80.8M
4
BDX icon
Becton Dickinson
BDX
+$68.3M
5
SHW icon
Sherwin-Williams
SHW
+$62.8M

Sector Composition

Rank Sector Weight
1 Healthcare 10.2%
2 Technology 10.13%
3 Utilities 6.69%
4 Consumer Discretionary 6.52%
5 Industrials 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HES
201
DELISTED
Hess
HES
$13.4M 0.09%
+90,517
New +$13.9M
PFE icon
202
Pfizer
PFE
$148B
$13.3M 0.09%
+475,997
New +$13.1M
BA icon
203
PUT
Boeing
BA
$184B
$13.1M 0.09%
72,000
+42,400
+143% +$7.56M
WRK
204
DELISTED
WestRock Company
WRK
$13.1M 0.09%
260,564
+238,292
+1,070% +$12M
ALL icon
205
Allstate
ALL
$70.5B
$13.1M 0.09%
81,820
+60,123
+277% +$10M
COHR icon
206
Coherent
COHR
$66B
$12.9M 0.09%
178,595
+134,375
+304% +$8.08M
KGC icon
207
Kinross Gold
KGC
$30.5B
$12.9M 0.09%
1,550,216
+1,388,171
+857% +$10M
BKNG icon
208
Booking.com
BKNG
$156B
$12.9M 0.09%
81,300
-149,550
-65% -$22.2M
SNDX icon
209
Syndax Pharmaceuticals
SNDX
$1.75B
$12.8M 0.09%
625,723
+339,393
+119% +$7.1M
KNTK icon
210
Kinetik
KNTK
$3.71B
$12.8M 0.09%
309,895
+137,746
+80% +$5.47M
NVS icon
211
Novartis
NVS
$293B
$12.8M 0.09%
+120,170
New +$12.1M
AROC icon
212
Archrock
AROC
$5.88B
$12.8M 0.09%
+631,494
New +$12.5M
OC icon
213
Owens Corning
OC
$12.2B
$12.7M 0.09%
73,243
+47,874
+189% +$8.29M
GH icon
214
Guardant Health
GH
$21.4B
$12.7M 0.09%
440,379
+420,093
+2,071% +$9.78M
AME icon
215
Ametek
AME
$57.4B
$12.7M 0.09%
+76,231
New +$13.2M
LBRT icon
216
Liberty Energy
LBRT
$3.32B
$12.6M 0.09%
+604,847
New +$13.5M
SR icon
217
Spire
SR
$4.78B
$12.5M 0.09%
205,331
+191,907
+1,430% +$11.6M
TGT icon
218
Target
TGT
$66.7B
$12.5M 0.09%
84,196
+32,228
+62% +$5.07M
NOV icon
219
NOV
NOV
$7.14B
$12.4M 0.08%
653,005
+539,388
+475% +$10.1M
UHS icon
220
Universal Health Services
UHS
$10.3B
$12.4M 0.08%
66,868
+2,875
+4% +$509K
MT icon
221
ArcelorMittal
MT
$55.6B
$12.3M 0.08%
+534,462
New +$13.7M
TENB icon
222
Tenable Holdings
TENB
$3.88B
$12.2M 0.08%
+278,971
New +$12.3M
IQV icon
223
IQVIA
IQV
$38B
$12.1M 0.08%
+57,362
New +$13M
SBRA icon
224
Sabra Healthcare REIT
SBRA
$5.33B
$12.1M 0.08%
+787,018
New +$11.2M
BSY icon
225
Bentley Systems
BSY
$10.7B
$12M 0.08%
242,432
+123,830
+104% +$6.43M

Similar funds

ExodusPoint Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, ExodusPoint Capital Management held 2,110 positions worth $14.7B, up 12% from $13.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

ExodusPoint Capital Management's Q2 2024 filing shows 660 new, 423 increased, 368 reduced and 648 closed positions. Its largest new stake was Coca-Cola: 936,563 shares worth $59.6M. The largest sale was NVIDIA, an estimated $351M.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, up from 6.9% a quarter earlier, followed by Technology and Utilities.

  • ExodusPoint Capital Management's largest Q2 2024 buy was Coca-Cola: 936,563 shares worth $59.6M.
  • ExodusPoint Capital Management added most to Amazon in Q2 2024, an estimated $231M increase.
  • ExodusPoint Capital Management's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $351M.
  • ExodusPoint Capital Management fully exited Global Payments in Q2 2024, selling an estimated $202M.
  • ExodusPoint Capital Management's ten largest holdings make up 34% of its $14.7B portfolio in Q2 2024.
  • ExodusPoint Capital Management opened 660 new positions and closed 648 in Q2 2024.
  • ExodusPoint Capital Management's portfolio value rose 12% quarter-over-quarter to $14.7B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.